Cardiac complications attributed to hydroxychloroquine: a systematic review of the literature pre-COVID-19

G Fram, DD Wang, K Malette… - Current Cardiology …, 2021 - ingentaconnect.com
Introduction: Hydroxychloroquine has been used for rheumatological diseases for many
decades and is considered a safe medication. With the COVID-19 outbreak, there has been …

Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using in silico studies

HO Rasul, NV Thomas, DD Ghafour… - Journal of …, 2023 - Taylor & Francis
The largest threat to civilization since the Second World War is the spread of the new
coronavirus disease (COVID-19). Therefore, there is an urgent need for innovative …

Production and characterization of biocompatible nano‐carrier based on Fe3O4 for magnetically hydroxychloroquine drug delivery

MS Sadr, A Heydarinasab, HA Panahi… - Polymers for …, 2021 - Wiley Online Library
In this work, we attempted to produce a new biocompatible nano‐carrier based on the
Fe3O4 nanoparticles for drug delivery applications. The release profile of …

[HTML][HTML] Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression

L Xu, A Chockalingam, S Stewart, K Shea, MK Matta… - Toxicology Reports, 2020 - Elsevier
Opioids and benzodiazepines were frequently co-prescribed to patients with pain and
psychiatric or neurological disorders; however, co-prescription of these drugs increased the …

[HTML][HTML] Azathioprine and hydroxychloroquine overdose in Sjögren's syndrome patient with hypocalcemia: a case report

A Kooshki, O Mehrpour, S Nakhaee - Journal of Medical Case Reports, 2024 - Springer
Introduction Hydroxychloroquine and azathioprine have been routinely used to control and
treat primary and secondary Sjögren's syndrome, which potentially triggered some …

[HTML][HTML] Incidence, Risk Factors and Prognosis of Hypokalaemia in Patients with Normokalaemia at Hospital Admission

J Bhargava, S Viswanathan - Indian Journal of Endocrinology and …, 2023 - journals.lww.com
Background: Hypokalaemia (K+< 3.5 mmol/L) is observed in 20% of hospitalised patients.
Previous studies have often dealt with the symptoms, prevalence and risk factors in …

Identification of musk compounds as inhibitors of the main SARS-CoV-2 protease by molecular docking and molecular dynamics studies

A Belhassan, G Salgado… - Journal of the Serbian …, 2024 - shd-pub.org.rs
As new drug development is a long process, reuse of bioactives may be the answer to new
epidemics; thus, screening existing bioactive compounds against a new SARS-CoV-2 …

[HTML][HTML] Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment

G Aksel, MM Islam, T Aslan… - Turkish journal of …, 2020 - journals.lww.com
Hydroxychloroquine is one of the most commonly used drugs in COVID-19 treatment. In this
case report, we aimed to present a young patient whose QT interval was prolonged due to …

Кардиотоксичные лекарственные средства при лечении COVID-19

АС Змитрукевич… - Антибиотики и …, 2024 - antibiotics-chemotherapy.ru
Аннотация Актуальность. Пандемия COVID-19 вызвана вирусом SARS-CoV-2.
Кардиотоксичному потенциалу лекарственных средств, используемых при лечении …

[HTML][HTML] A computational predicting of possible inhibitors of the main SARS-CoV-2 protease found in Algerian herbal medicines

B Yabrir, A Belhassan, G Salgado Moran… - Revista Colombiana …, 2022 - scielo.org.co
COVID-19 is a zoonotic viral disease caused by the SARS-CoV-2 virus. Its abrupt outbreak
has caused a tremendous challenge to public health systems due to the rapid spread of the …